UBS Group
ACH

UBS Group’s Accendra Health ACH Stock Holding History

UBS Group’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,300
Closed -$42K – 8073
2019
Q1 		$42K Hold
10,300
– – ﹤0.01% 5689
2018
Q4 		$65K Buy
+10,300
New +$107K ﹤0.01% 5883

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's ACH Position: Q1 2026 in Review

UBS Group reduced its Accendra Health (ACH) stake by 63% in Q1 2026, selling an estimated $1.2M and leaving 308,734 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #5823.

UBS Group first reported a position in ACH in Q4 2014 and has held it in 46 quarters since. The position peaked at $6.99M in Q2 2025. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

  • UBS Group held 308,734 shares of Accendra Health worth $704K as of Q1 2026.
  • UBS Group sold 519,760 Accendra Health shares in Q1 2026, an estimated $1.2M.
  • Accendra Health made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5823 holding.
  • UBS Group first reported a position in Accendra Health in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Accendra Health position peaked at $6.99M in Q2 2025.
  • 142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.